Drop, which is developing smart kitchen appliance software, was backed by supply chain services company PCH in a previous round.

Taiho Pharmaceutical has invested in a series A round for the small-molecule therapy developer that now totals $21.6m.

The Cambridge genomics spinout has secured $5.4m in additional series A funding from drug maker Taiho Pharmaceutical.

GE Ventures, Kaiser Permanente Ventures and existing backer Illumina Ventures have helped Genome Medical take its total funding to $23m

KBP Biosciences, which is developing drugs for disease areas of unmet need, raised the series A funds from investors including Cash Capital.

The autonomous transportation developer hopes to introduce self-driving shuttle buses to Detroit by the middle of 2018.

KBP Biosciences, which is developing drugs for disease areas of unmet need, raised the series A funds from investors including Ping An Ventures.

Rewind Therapeutics, which is developing therapies for myelin-related diseases like MS, secured $18.3m in a Boehringer Ingelheim and Merck Group-backed round.

Cityblock, a care coordination platform incubated by Alphabet-owned Sidewalk Labs, has raised $20.8m from investors including Sidewalk.

The KU Leuven spinout is researching remedies for debilitating diseases of the nervous system such as multiple sclerosis.